News Check all IrsiCaixa scientific news in just one click. Breadcrumb Home News Achievement 04/03/2025 30 years of IrsiCaixa: the legacy of past pandemics to face those of the future Emerging pathogens 07/02/2025 Discovering the molecular footprint of a drug: how an anticancer drug can become a solution against multiple viruses HIV 29/01/2025 Interruption of HIV treatment: a new study guides the design of future clinical trials for an HIV cure HIV 29/11/2024 The viral reservoir, the main obstacle to eradicating HIV, is up to four times smaller in those who started treatment after 2007 26/11/2024 Can Ruti Campus remains a globally significant scientific centre due to its medical and research staff Vaccines Innovation 25/11/2024 Gilead Sciences acquires investigational assets for the HIV vaccine designed at IrsiCaixa and driven by AELIX Therapeutics HIV 17/10/2024 A low-activity virus sensitive to the immune system: the case of 5 children who keep HIV controlled without antiretroviral treatment HIV 16/10/2024 A pioneering study identifies protective mechanisms in people with HIV resistant to disease progression HIV 02/09/2024 The "Geneva patient": first case of HIV cure with stem cell transplant without protective mutation Pagination First Previous Page 1 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next Last
Achievement 04/03/2025 30 years of IrsiCaixa: the legacy of past pandemics to face those of the future
Emerging pathogens 07/02/2025 Discovering the molecular footprint of a drug: how an anticancer drug can become a solution against multiple viruses
HIV 29/01/2025 Interruption of HIV treatment: a new study guides the design of future clinical trials for an HIV cure
HIV 29/11/2024 The viral reservoir, the main obstacle to eradicating HIV, is up to four times smaller in those who started treatment after 2007
26/11/2024 Can Ruti Campus remains a globally significant scientific centre due to its medical and research staff
Vaccines Innovation 25/11/2024 Gilead Sciences acquires investigational assets for the HIV vaccine designed at IrsiCaixa and driven by AELIX Therapeutics
HIV 17/10/2024 A low-activity virus sensitive to the immune system: the case of 5 children who keep HIV controlled without antiretroviral treatment
HIV 16/10/2024 A pioneering study identifies protective mechanisms in people with HIV resistant to disease progression
HIV 02/09/2024 The "Geneva patient": first case of HIV cure with stem cell transplant without protective mutation